PI Industries will interact with analysts and investors on August 19, 2026, during the Motilal Oswal 22nd Annual Global Investor Conference in Mumbai.

The company disclosed the engagement pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The session will feature a mix of one-on-one and group meetings.

Meeting Details

The company stated that no unpublished price-sensitive information is proposed to be shared during the meeting. The schedule is subject to change due to exigencies on the part of the investors or the company.

Shruti Joshi, Company Secretary and Compliance Officer, signed the disclosure filed with BSE and NSE on August 12, 2026.

Pi Industries has maintained its FY27 revenue growth guidance at low single digits, according to its latest conference call update. The company also flagged sequential delays in its pharma business order book and acknowledged that it is working to optimise its product mix amid ongoing margin pressure. Additionally, Pi Industries highlighted an active research and development pipeline, with multiple molecules under development across its R&D and Contract and Specialty Manufacturing (CSM) segments, and noted demand-driven pricing pressure in Q1.

FY27 Revenue Growth Guidance

Pi Industries has kept its revenue growth guidance for FY27 at low single digits, signaling a measured outlook for the near term. The company's conservative guidance reflects the current market environment, where demand challenges are exerting pressure on pricing.

Pharma Order Book and Margin Pressure

In a notable development, Pi Industries has flagged sequential delays in its pharma business order book. The company is also actively working to optimise its product mix as margins remain under pressure. These challenges reflect the broader operational headwinds the company is navigating across its business segments.

R&D and CSM Pipeline

On the product development front, Pi Industries reported that many molecules are currently in the R&D and CSM pipeline. The company indicated that 2-3 new products are expected to be launched soon, reflecting continued investment in its innovation and manufacturing capabilities.

Demand and Pricing Dynamics

The company acknowledged that demand challenges in Q1 have automatically translated into pricing pressure. This dynamic underscores the broader market headwinds facing the agrochemical and specialty chemicals sector, which Pi Industries operates in across both domestic and international markets.

Global Market Expansion Focus

Beyond near-term guidance, Pi Industries has also identified growth opportunities across several key global markets. The company has specifically pointed to Brazil, Mexico, Europe, and the United States as regions of strategic interest for future business development, reflecting a geographically diversified international strategy.